Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes

Journal of Neurology

Volumn 263, Issue 7, 2016, Pages 1349-1360

  Sepúlveda, Maria ^a,b   Armangue, Thaís ^a,b   Martinez Hernandez, Eugenia ^b   Arrambide, Georgina ^c   Sola Valls, Nuria ^a,b   Sabater, Lidia ^b   Téllez, Nieves ^d   Midaglia, Luciana ^e   Ariño, Helena ^a,b   Peschl, Patrick ^f   Reindl, Markus ^f   Rovira, Alex ^g   Montalban, Xavier ^c   Blanco, Yolanda ^a,b   Dalmau, Josep ^b,h,i   Graus, Francesc ^a,b   Saiz, Albert ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^e Alvaro Cunqueiro University Hospital of Vigo   (Spain)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Antibodies to myelin oligodendrocyte glycoprotein; Cell based assays; Immunohistochemistry; Longitudinally extensive myelitis; MRI; Neuromyelitis optica; Optic neuritis

Indexed keywords

EPITOPE; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; AQUAPORIN 4; AUTOANTIBODY;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADULT; AGED; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BRAIN STEM; BRAIN TISSUE; CLINICAL FEATURE; DEMYELINATING DISEASE; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MYELITIS; MYELOOPTIC NEUROPATHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NEURITIS; OUTCOME ASSESSMENT; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; RODENT; ADOLESCENT; ANIMAL; BLOOD; BRAIN; DISABILITY; FOLLOW UP; HEK293 CELL LINE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; AQUAPORIN 4; AUTOANTIBODIES; AUTOIMMUNITY; BRAIN; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; HEK293 CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUROMYELITIS OPTICA; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84965002383     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-016-8147-7     Document Type: Article

References (30)

1. Mayer MC, Breithaupt C, Reindl M et al (2013) Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. J Immunol 191(7):3594–3604
2. Reindl M, Di Pauli F, Rostásy K, Berger T (2013) The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 9(8):455–461
3. Pröbstel AK, Dornmair K, Bittner R et al (2011) Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 77(6):580–588
4. Ketelslegers IA, Van Pelt DE, Bryde S et al (2015) Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating syndromes cohort. Mult Scler 21(12):1513–1520
5. Kitley J, Waters P, Woodhall M et al (2014) Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 71(3):276–283
6. Sato DK, Callegaro D, Lana-Peixoto MA et al (2014) Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82(6):474–481
7. Höftberger R, Sepulveda M, Armangue T et al (2015) Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler 21(7):866–874
8. Kim SM, Woodhall MR, Kim JS et al (2015) Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm 2(6):e163
9. Lechner C, Baumann M, Hennes EM et al (2015) Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2015-311743
10. Huppke P, Rostasy K, Karenfort M et al (2013) Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler 19(7):941–946
11. Titulaer MJ, Höftberger R, Izuka T et al (2014) Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis. Ann Neurol 75(3):411–428
12. Martinez-Hernandez E, Sepulveda M, Rostásy K et al (2015) Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis. JAMA Neurol 72(2):187–193
13. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452
14. Höftberger R, Sabater L, Marignier R et al (2013) An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays. PLoS One 8(11):e79083
15. Sabater L, Saiz A, Dalmau J, Graus F (2016) Pitfalls in the detection of CV2 (CRMP5) antibodies. J Neuroimmunol 290:80–83
16. Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177–189
17. Krupp LB, Tardieu M, Amato MP et al (2013) International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 19(10):1261–1267
18. Kidd D, Burton B, Plant GT, Graham EM (2003) Chronic relapsing inflammatory optic neuropathy (CRION). Brain 126(Pt 2):276–284
19. Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol 58(6):840–846
20. Wingerchuk DM, Lennon VA, Pittock SJ et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485–1489
21. Waters P, Woodhall M, O’Connor KC et al (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2(3):e89
22. Van Pelt ED, Wong YY, Ketelslegers IA et al (2016) Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands. Eur J Neurol 23(3):580–587
23. Cobo-Calvo A, Sepulveda M, Bernard-Valnet R et al (2016) Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: clinical and prognostic implications. Mult Scler 22(3):312–319
24. Flanagan EP, Weinshenker BG, Krecke KN et al (2015) Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol 72(1):81–87
25. Rostasy K, Mader S, Schanda K et al (2012) Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol 69(6):752–756
26. Bettelli E, Pagany M, Weiner HL et al (2003) Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 197(9):1073–1081
27. Storch MK, Stefferl A, Brehm U et al (1998) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8(4):681–694
28. Betteli E, Baeten D, Jäger A et al (2006) Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest 116(9):2393–2402
29. Höftberger R, Dalmau J, Graus F (2012) Clinical neuropathology practice guide 5-2012: updated guideline for the diagnosis of antineuronal antibodies. Clin Neuropathol 31(5):337–341
30. Paty DW, Oger JF, Kastrukoff LF et al. (1988) MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180–185